SARS-CoV-2 Mpro-IN-9
Based on 1 Customer Validation
SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM).
For research use only. We do not sell to patients.
- Purity: 99.31%
- CAS No.: 2754370-99-3
- Formula: C20H14N2O4
- Molecular Weight:346.34
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
IC50: 0.085 μM (SARS-CoV-2), EC50: 1.10 μM (viral replication)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Vero C1008 | CC50 |
>50 μM
Compound: C7
|
Cytotoxicity against african green monkey Vero E6 cells by CCK-8 assay
Cytotoxicity against african green monkey Vero E6 cells by CCK-8 assay
|
[PMID: 37257212] |
Chemical Information
-
CAS No. 2754370-99-3
-
Appearance Solid
-
Molecular Weight 346.34
-
Formula C20H14N2O4
-
Color White to light brown
-
SMILES
O=C1N(C2=CC=CC=C2)C(C3=CC=CC=C3)=NC4=C1C(O)=C(O)C(O)=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)